Plain-English translation of NCT06411795 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
After pancreatic surgery, pain management is crucial for recovery. This trial compares two approaches: one using (a long-acting numbing medication injected near your abdominal muscles) versus a traditional spinal catheter that delivers pain medication continuously for up to three days after surgery. The study wants to know if the newer injection method works as well as the traditional approach.
Pancreatic surgery is major and causes significant pain. While epidural catheters are standard for pain relief, they require careful monitoring and can sometimes cause complications. This study explores whether a single injection of the medication before surgery might be just as effective, potentially simpler and safer for patients.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of two pain management methods before your pancreatic surgery. If assigned to the epidural group, a catheter will be placed in your back and deliver pain medication continuously for up to 72 hours after surgery. If assigned to the injection group, you'll receive an ultrasound-guided injection of numbing medication into your abdominal muscle before surgery. Both groups will be monitored for pain control and recovery, with surveys about your experience and comfort.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States